title: Do the sites of metastases provide additional information regarding prognosis and biology in renal cell carcinoma?
authors.affiliation: Department of Medicine, Section of Hematology-Oncology, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL, USA. Electronic address: gsonpavde@uabmc.edu.
authors.forename: Guru
authors.initials: G
authors.lastname: Sonpavde
authors.affiliation: Department of Urology, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL, USA.
authors.forename: Sunil
authors.initials: S
authors.lastname: Sudarshan
authors.affiliation: Institut Gustave Roussy, Villejuif, France.
authors.forename: Bernard
authors.initials: B
authors.lastname: Escudier
mesh_terms: D001859:Bone Neoplasms / Q000556:secondary*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000556:secondary*; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D008113:Liver Neoplasms / Q000556:secondary*; D008297:Male